Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments
AssigneeProyecto De Biomedicina Cima, S.L.
InventorsJosune Orbe Lopategui, Jose Antonio Rodriguez Garcia, Jose Antonio Paramo Fernandez, Rosario Serrano Vargas
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of matrix metalloproteinase MMP-10 in the preparation of a pharmaceutical composition useful for thrombolytic therapy, it also being possible for said composition to contain a plasminogen activator. Additionally, the present invention relates to said pharmaceutical composition for the treatment of thrombotic disorders.
Claims14
A method for thrombolytic treatment and therapy comprising administering to a patient in need thereof a therapeutically effective quantity of a matrix metalloproteinase-10 (MMP-10).
Dependencies are inferred from the claim text.